Molecular Pathogenesis of Gastric Cancer

다국어 초록 (Multilingual Abstract)

In this article, I will survey the major genetic susceptibility and somatic genetic alterations involved in gastric cancer and adenoma. These include germline and somatic genetic alterations in oncogenes, tumor suppressor genes, and apoptosis-related genes. A small proportion of gastric cancers arise as a consequence of hereditary predisposition caused by specific germline mutations in E-cadherin, mismatch repair genes, adenomatous polyposis coli,and STK11. Aberrant expression of activation induced cytidine deaminase, triggered by Helicobacter pylori infection, accumulates with genetic mutations of oncogenes and tumor suppressor genes, including p53 and CTNNB1. Inactivation of trefoil factor family 1, which is a gastric specific tumor suppressor, occurs in gastric adenomas and cancers. Ectopic expression of CDX2 leads to intestinal metaplasia and defective Cdx2 expression accelerates the transformation of metaplastic cells to gastric cancer. Genetic alterations of p53 and genes related to Wnt signaling pathway and microsatellite instability occur early in the development of gastric carcinoma, indicating that detection of certain genetic alterations in adenomas may be indicative of malignant transformation. In addition, inactivation of apoptosis-inducing gene caused by mutations may be an escaping mechanism against apoptotic cell death and contribute to the progression of gastric cancer. Although the results of many studies are contradictory with one another, genetic alterations in oncogenes and tumor suppressor genes are present even in gastric adenoma and increase in frequency during multistep gastric carcinogenesis. Genetic alterations described herein, and from as yet unidentified target genes in gastric cancer cells, will guide us towards more effective risk assessment, diagnosis, and treatment.

참고문헌 (Reference)

1 조용구, "위암에서 여러 종양억제유전자 부위의 이형접합성 소실과 현미 부수체 불안정성" 대한위암학회 3 (3): 214-220, 2003

2 박원상, "위암에서 발견된 돌연변이형 Fas 단백의 기능적 결함" 대한위암학회 3 (3): 186-190, 2003

3 Müller W, "pS2 protein in gastric carcinoma and normal gastric mucosa: association with clincopathological parameters and patient survival" 171 : 263-269, 1993

4 Uchino S, "p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer" 54 : 759-764, 1993

5 Vousden KH, "p53 in health and disease" 8 : 275-283, 2007

6 Tohdo H, "p53 gene mutations in gastric adenomas" 63 : 191-195, 1993

7 Peifer M, "Wnt signaling in oncogenesis and embryogenesis a look outside the nucleus" 287 : 1606-1609, 2000

8 Wallace MH, "Upper gastrointestinal disease in patients with familial adenomatous polypsis" 85 : 742-750, 1998

9 Wallach D, "Tumor necrosis factor receptor and Fas signaling mechanisms" 17 : 331-367, 1999

10 Wong WM, "Trefoil peptides" 44 : 890-895, 1999

11 Yio X, "Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways" 130 : 1696-1706, 2006

12 Nishimura T, "Total number of genome alterations in sporadic gastrointestinal cancer inferred from pooled analyses in the literature" 29 : 343-350, 2008

13 Rucci F, "Tissue-specific sensitivity to AID expression in transgenic mouse models" 377 : 150-158, 2006

14 Lorenzo HK, "Therapeutic potential of AIF-mediated caspase-independent programmed cell death" 10 : 235-255, 2007

15 Lauren P, "The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification" 64 : 31-49, 1965

16 Calnan DP, "The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS" 188 : 312-317, 1999

17 Seib T, "The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3" 40 : 200-202, 1997

18 Maesawa C, "The sequential accumulation of genetic alterations characteristic of the colorectal adenomacarcinoma sequence does not occur between gastric adenoma and adenocarcinoma" 176 : 249-258, 1995

19 Polakis P, "The many ways of Wnt in cancer" 17 : 45-51, 2007

20 Taylor DN, "The epidemiology of Helicobacter pylori infection" 13 : 42-59, 1991

21 Nowell PC, "The clonal evolution of tumor cell populations" 194 : 23-28, 1976

22 Lustig B, "The Wnt signaling pathway and its role in tumor development" 129 : 199-221, 2003

23 Peter ME, "The CD95 (APO-1/Fas) DISC and beyond" 10 : 26-35, 2003

24 Antonsson B, "The Bcl-2 protein family" 256 : 50-57, 2000

25 Muramatsu M, "Specific expression of activationinduced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells" 274 : 18470-18476, 1999

26 Hollstein M, "Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation" 24 : 141-146, 1996

27 Park WS, "Somatic mutations of the trefoil factor family 1 gene in gastric cancer" 119 : 691-698, 2000

28 Kim CJ, "Somatic mutations of the beta-TRCP gene in gastric cancer" 115 : 127-133, 2007

29 Park WS, "Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer" 193 : 162-168, 2001

30 Wright NA, "Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer" 408 : 121-123, 1997

31 Leung WK, "Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients" 14 : 2982-2986, 2005

32 Ramesh S, "Reduction in membranous expression of beta-catenin and increased cytoplasmic Ecadherin expression predict poor survival in gastric cancer" 81 : 1392-1397, 1999

33 Kim CJ, "Pin1 gene mutation is a rare event in gastric cancer" 114 : 518-522, 2006

34 Correa P, "Phenotypic and genotypic events in gastric carcinogenesis" 54 : 1914s-1943s, 1994

35 Ottini L, "Patterns of genomic instability in gastric cancer: clinical implications and perspectives" (7) : vii97-102, 2006

36 Machado JC, "Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa" 5 : 169-179, 1996

37 Renkonen-Sinisalo L, "No support for endoscopic surveillance for gastric cancer in hereditary nonpolyposis colorectal cancer" 37 : 574-577, 2002

38 Candidus S, "No evidence for mutations in the alpha-and beta-catenin genes in human gastric and breast carcinomas" 56 : 49-52, 1996

39 Tamura G, "Mutations of the APC gene occur during early stages of gastric adenoma development" 54 : 1149-1151, 1994

40 Smith G, "Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer" 99 : 9433-9438, 2002

41 Soung YH, "Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas" 114 : 292-297, 2006

42 Nagase H, "Mutation of the APC (adenomatous polyposis coli) gene" 2 : 425-434, 1993

43 Loeb LA, "Multiple mutations and cancer" 100 : 776-781, 2003

44 IARC Working group, "Monographs on the evaluation of the carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori" 61 : 177-241, 1994

45 Tamura G, "Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach" 46 : 834-841, 1996

46 Stadtlander CT, "Molecular epidemiology, pathogenesis and prevention of gastric cancer" 20 : 2195-2208, 1999

47 Tamura G, "Molecular characterization of undifferentiated-type gastric carcinoma" 81 : 593-598, 2001

48 Park WS, "Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers" 159 : 15-21, 2000

49 Kuipers EJ, "Long-term sequelae of Helicobacter pylori gastritis" 345 : 1525-1528, 1995

50 Kinzler KW, "Lessons from hereditary colorectal cancer" 87 : 159-170, 1996

51 Lee JH, "Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma" 161 : 611-618, 2002

52 Giardiello FM, "Increased risk of cancer in the Peutz-Jeghers syndrome" 316 : 1511-1514, 1987

53 Boardman LA, "Increased risk for cancer in patients with the Peutz-Jeghers syndrome" 128 : 896-899, 1998

54 Ebert MP, "Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer" 23 : 87-91, 2002

55 Ahn YO, "Incidence estimation of stomach cancer among Koreans" 6 : 7-14, 1991

56 Park WS, "Inactivating mutations of the caspase-10 gene in gastric cancer" 21 : 2919-2925, 2002

57 Kim CJ, "Inactivating mutations of the Siah-1 gene in gastric cancer" 23 : 8591-8596, 2004

58 Park WS, "Inactivating mutations of KILLER/DR5 gene in gastric cancers" 121 : 1219-1225, 2001

59 Lee JH, "Inactivating mutation of the pro-apoptotic gene BID in gastric cancer" 202 : 439-445, 2004

60 Gayther SA, "Identification of germ-line E-cadherin mutations in gastric cancer families of European origin" 58 : 4086-4089, 1998

61 Fleisher AS, "Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability" 59 : 1090-1095, 1999

62 Matsumoto Y, "Helicobacter pylori infection triggers aberrant expression of activation- induced cytidine deaminase in gastric epithelium" 13 : 470-476, 2007

63 Machado AM, "Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells" 15 : 2995-3002, 2009

64 Watanabe T, "Helicobacter pylori infection induces gastric cancer in Mongolian gerbils" 115 : 642-648, 1998

65 Graham DY, "Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model" 113 : 1983-1991, 1997

66 Suerbaum S, "Helicobacter pylori infection" 347 : 1175-1186, 2002

67 Yanai A, "Helicobacter pylori induces antiapoptosis through nuclear factor-kappaB activation" 188 : 1741-1751, 2003

68 Peek RM Jr, "Helicobacter pylori and gastrointes-tinal tract adenocarcinomas" 2 : 28-37, 2002

69 Umeda M, "Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability" 284 : 22166-22172, 2009

70 Yoon KA, "Germline mutations of E-cadherin gene in Korean familial gastric cancer patients" 44 : 177-180, 1999

71 Lynch HT, "Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review" 104 : 1535-1549, 1993

72 Hamajima N, "Genetic factors involved in the development of Helicobacter pylori-related gastric cancer" 97 : 1129-1138, 2006

73 Song JH, "Genetic alterations of the Cdx2 gene in gastric cancer" 116 : 74-80, 2008

74 Abraham SC, "Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes" 16 : 786-795, 2003

75 Yamamoto H, "Gastrointestinal cancer of the microsatellite mutator phenotype pathway" 37 : 153-163, 2002

76 Kimura K, "Gastritis and gastric cancer. Asia" 29 : 609-621, 2000

77 Lefebvre O, "Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein" 274 : 259-262, 1996

78 Iacopetta BJ, "Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes" 187 : 428-432, 1999

79 Sipponen P, "Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data" 35 : 173-177, 1985

80 Lee HJ, "Gastric cancer in Korea" 5 : 177-182, 2002

81 Tajima Y, "Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background" 12 : 6469-6479, 2006

82 Rocco A, "Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression" (7) : vii103-108, 2006

83 Park WS, "Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer" 59 : 4257-4260, 1999

84 Akiyama Y, "Frequent microsatellite instabilities and analyses of the related genes in familial gastric cancers" 87 : 595-601, 1996

85 Aarnio M, "Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome" 74 : 551-555, 1997

86 Stone P, "Fatigue in advanced cancer: a prospective controlled cross-sectional study" 79 : 1479-1486, 1999

87 Lim SC, "Fas-related apoptosis in gastric adenocarcinoma" 10 : 57-63, 2003

88 Nagata S, "Fas ligand-induced apoptosis" 33 : 29-55, 1999

89 Henry JA, "Expression of the pNR-2/pS2 protein in diverse human epithelial tumours" 64 : 677-682, 1991

90 Eda A, "Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia" 37 : 94-100, 2002

91 Osaki M, "Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis" 4 : 198-205, 2001

92 Bai YQ, "Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach" 176 : 47-55, 2002

93 Guilford PJ, "E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer" 14 : 249-255, 1999

94 Mutoh H, "Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice" 64 : 7740-7747, 2004

95 Sun A, "Detection of cancer clones in human gastric adenoma by increased DNA-instability and other biomarkers" 47 : 111-122, 2003

96 Nakamura K, "Depressed adenoma of the stomach" 62 : 2197-2202, 1998

97 Peltomaki P, "Deficient DNA mismatch repair: A common etiologic factor for colon cancer" 121 : 1005-1008, 2001

98 Kunkel TA, "DNA replication fidelity" 69 : 497-529, 2000

99 Yuasa Y, "Control of gut differentiation and intestinal-type gastric carcinogenesis" 3 : 592-600, 2003

100 Drummond FJ, "Colon carbonic anhydrase 1: transactivation of gene expression by the homeodomain protein Cdx2" 423 : 218-222, 1998

101 Aaltonen LA, "Clues to the pathogenesis of familial colorectal cancer" 260 : 812-816, 1993

102 Kashiwagi K, "Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis" 82 : 1814-1818, 2000

103 Powell SM, "Characterization of the APC gene in sporadic gastric adenocarcinomas" 12 : 1953-1959, 1996

104 Silberg DG, "Cdx1 and cdx2 expression during intestinal development" 119 : 961-971, 2000

105 Jemal A, "Cancer statistics, 2007" 57 : 43-66, 2007

106 Bai YQ, "CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene" 22 : 7942-7949, 2003

107 Guo B, "Bcl-G, a novel pro-apoptotic member of the Bcl-2 family" 276 : 2780-2785, 2001

108 Chen G, "Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK" 239 : 626-632, 1997

109 Varley JM, "An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53" 32 : 942-945, 1995

110 Kim CJ, "Activation-induced cytidine deaminase expression in gastric cancer" 28 : 333-339, 2007

111 Revy P, "Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper- IgM syndrome (HIGM2)" 102 : 565-575, 2000

112 Kim JJ, "Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability" 79 : 1113-1120, 1999

113 Thim L, "A new family of growth factor-like peptides. ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)" 250 : 85-90, 1989

114 Fearon ER, "A genetic model for colorectal tumorigenesis" 61 : 759-767, 1990

115 Boland CR, "A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer" 58 : 5248-5257, 1998